RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges
RxSight, Inc. Common Stock · OPHTHALMIC GOODS · Now $5.24
-10% in 7d after detection
Post-detection moves
1h
—
1d
+3.5%
3d
+2.3%
7d
-10%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS